$5.00
0.377.99%
Pre-Market: Feb 21, 8:51 AM EDT
Comments
Loading...
Cara Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CARA | Benzinga
Cara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS Estimate
$-2.040
Quarterly Revenue Estimate
$1.60M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$8.69M
Analyze the earnings history of Cara Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cara Therapeutics (CARA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-1.80 | $-2.88 | 37.5 % |
| Q2 | 2024-08-14 | $-4.44 | $-3.24 | -37.0 % |
| Q1 | 2024-05-13 | $-6.72 | $-4.80 | -40.0 % |
| Q4 | 2024-03-04 | $-7.08 | $-0.41 | -1626.8 % |
Cara Therapeutics (CARA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $2.56M | $1.74M | 46.9 % |
| Q2 | 2024-08-14 | $991.00K | $1.17M | -15.3 % |
| Q1 | 2024-05-13 | $2.13M | $1.69M | 26.3 % |
| Q4 | 2024-03-04 | $3.00M | $9.42M | -68.1 % |
FAQ
When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?
Cara Therapeutics (CARA) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Cara Therapeutics (NASDAQ:CARA)?
The Actual EPS was $-1.80, which beat the estimate of $-2.88.
What were Cara Therapeutics’s (NASDAQ:CARA) revenues?
The Actual Revenue was $2.6M, which beat the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.